i3 Genesis
Funding for early-stage
healthcare technologies
in development at Mount Sinai.
About i3 Genesis
i3 Genesis is an annual funding opportunity for early-stage healthcare technologies with clear potential for commercialization. Part of MSIP’s i3 Family of Funds, this opportunity aims to support and translate innovations by providing funding to achieve value inflection points.
i3 Genesis funding is not available at this time. Please check back on this page for updates.
How it Works
Submitted proposals during the Request for Proposals (RFP) period are evaluated by a review panel of experts from the MSIP Business Development team in fields including digital health, medical devices, and therapeutics. Typically, some are selected to pitch their proposal to the review panel during a virtual session conducted via Zoom. Proposals are judged and scored based on project novelty, feasibility, and market risks against the budget and milestones provided.
How to Apply
i3 Genesis funding is not available at this time. Please check back on this page for updates.
Contact Us
For more information, please reach out to Louise Lammers, PhD, Director of Business Development, Emerging Assets at louise.lammers@mssm.edu or William Chiang, PhD, Business Development Consultant, at william.chiang@mssm.edu.